Md. Fleming et al., ABSENCE OF DENDRITIC RETICULUM-CELL STAINING IS HELPFUL FOR DISTINGUISHING T-CELL-RICH B-CELL LYMPHOMA FROM LYMPHOCYTE PREDOMINANCE HODGKINS-DISEASE, Applied immunohistochemistry, 6(1), 1998, pp. 16-22
Citations number
23
Categorie Soggetti
Medical Laboratory Technology","Biochemical Research Methods
T-cell-rich B-cell lymphoma (TCRBCL), a variant of B-cell non-Hodgkin'
s lymphoma associated with an extensive nonneoplastic infiltrate of T
cells, may be difficult to distinguish from other lymphoproliferative
disorders, particularly when only limited biopsy specimens are availab
le. The differential diagnosis usually includes lymphocyte predominanc
e Hodgkin's disease (LPHD), which, although typically associated with
nodular infiltrates, may exhibit a mixed nodular and diffuse or diffus
e pattern of infiltration, with large neoplastic cells interspersed wi
th small lymphocytes in a pattern that resembles TCRBCL. LPHD typicall
y has a well-defined dendritic reticulum cell (DRC) network associated
with the neoplastic infiltrate, but the presence of DRC in TCRBCL has
not been well studied. To determine whether DRC staining is a useful
marker to distinguish TCRBCL from LPHD, we examined formalin-fixed, pa
raffin-embedded tissue from lesions that fulfill the histologic and im
munophenotypic criteria for TCRBCL for DRC staining with antibodies fo
r CD21 and low-affinity nerve growth factor (LNGFR) receptor and compa
red this staining with that seen in typical cases of LPHD. As expected
, 17 of 17 cases (100%) of LPHD exhibited DRC staining in an expanded
follicular meshwork pattern. In contrast, none of the 15 cases of TCRB
CL, including cases rich in histiocytes, exhibited DRC staining associ
ated with the neoplastic infiltrate, except in residual, nonneoplastic
germinal centers. We conclude that DRC staining is helpful for distin
guishing TCRBCL from LPHD.